Salvo Health Announces $8.5M Series A to Advance Hybrid Care Future for GI and Metabolic Treatment
Summary
Salvo Health raised an $8.5M Series A led by ManchesterStory, City Light Capital, and Threshold Ventures with participation from several new and existing investors. The company provides a hybrid, AI-enhanced continuous care platform that helps GI practices adopt multidisciplinary, value-focused care and reports rapid traction, including 800% YoY patient and revenue growth and agreements with 801 GI providers (16% of independent U.S. GIs). Enterprise customers include three of the four largest GI practices, collectively seeing over 1.1 million GI patients annually. Salvo plans to use the proceeds to expand its engineering team around an AI roadmap and hire registered dietitians, behavioral health professionals, and nurses to meet rising patient demand.